Evidence map›Paper›PMID 39125795›Full record

ReviewInternational journal of molecular sciences2024

Perspectives and Possibilities for New Antimicrobial Agents in the Treatment and Control of

Weronika Jabłońska, Marcin Gołębiewski, Magdalena Kot, Henadzi Mardan, Bartosz Pawliński, Aleksandra Kalińska

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weronika JabłońskaDepartment of Animal Breeding, Institute of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland.ORCID 0009-0005-9117-8115
Marcin GołębiewskiDepartment of Animal Breeding, Institute of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland.ORCID 0000-0003-0645-433X
Magdalena KotDepartment of Animal Breeding, Institute of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland.ORCID 0000-0002-2002-163X
Henadzi MardanDepartment of Animal Breeding, Institute of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland.
Bartosz PawlińskiDepartment of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland.ORCID 0000-0002-2307-8922
Aleksandra KalińskaDepartment of Animal Breeding, Institute of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Innovative approaches in nanotechnology provide a potentially promising alternative to untreatable cases of

Indexed as

Anti-Infective AgentsMastitis, BovineProtothecaAnimalsCattleFemaleHumansMastitisAnti-Infective Agentsalgaeessential oilnanobiotechnologyPrototheca spp.udder inflammation

Identifiers

PMID39125795
PMCPMC11311760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.